يعرض 1 - 10 نتائج من 79 نتيجة بحث عن '"Antidrug antibodies"', وقت الاستعلام: 0.75s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية

    المساهمون: Reumatologian yksikkö, Helsinki University Hospital Area, HUS Internal Medicine and Rehabilitation, HUS Inflammation Center, Department of Medicine, HYKS erva, Päijät-Häme Welfare Consortium, Invärtes medicin enhet, TRIMM - Translational Immunology Research Program, Research Programs Unit

    وصف الملف: application/pdf

    العلاقة: Open access funding provided by University of Helsinki including Helsinki University Central Hospital. This study was supported by an independent research grant from Pfizer (Grant Number WI189027). Pfizer did not have any influence on planning, executing, interpretation or reporting of the data.; FinADASpA Study Grp , Hiltunen , J , Parmanne , P , Sokka , T , Lamberg , T , Isomäki , P , Kaipiainen-Seppänen , O , Peltomaa , R , Uutela , T , Pirila , L , Taimen , K , Kauppi , M J , Yli-Kerttula , T , Tuompo , R , Relas , H , Kortelainen , S , Paalanen , K , Asikainen , J , Ekman , P , Santisteban , A , Vidqvist , K-L , Tadesse , K , Romu , M , Borodina , J , Elfving , P , Valleala , H , Leirisalo-Repo , M , Rantalaiho , M , Kautiainen , H , Jokiranta , T S & Eklund , K K 2022 , ' Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis ' , Rheumatology International , vol. 42 , pp. 1015–1025 . https://doi.org/10.1007/s00296-021-04955-8Test; http://hdl.handle.net/10138/353365Test; 80e499cd-8d52-4ae5-883d-939444727242; 000682442300001

  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية

    المساهمون: Pediatrics, School of Medicine

    المصدر: PMC

    وصف الملف: application/pdf

    العلاقة: Frontiers in Immunology; Biswas M, So K, Bertolini TB, et al. Distinct functions and transcriptional signatures in orally induced regulatory T cell populations. Front Immunol. 2023;14:1278184. Published 2023 Oct 26. doi:10.3389/fimmu.2023.1278184; https://hdl.handle.net/1805/40101Test

  6. 6
  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية

    المصدر: Dorn-Rasmussen , M , Buhl , S , Brynskov , J , Bay , J T , Bolstad , N , Klausen , T W , Warren , D J , Ainsworth , M A & Steenholdt , C 2022 , ' Drug Levels Associated with Optimal Discrimination Between Remission and Non-Remission and Comparison of Antibody Assays During First Year of Stable Infliximab Maintenance Therapy in Inflammatory Bowel Disease ' , Therapeutic Drug Monitoring , vol. 44 , no. 2 , pp. 290-300 . https://doi.org/10.1097/FTD.0000000000000913Test

    وصف الملف: application/pdf

  10. 10
    دورية أكاديمية